JP2005185241A - Fermented health food product and method for producing the same - Google Patents
Fermented health food product and method for producing the same Download PDFInfo
- Publication number
- JP2005185241A JP2005185241A JP2003433880A JP2003433880A JP2005185241A JP 2005185241 A JP2005185241 A JP 2005185241A JP 2003433880 A JP2003433880 A JP 2003433880A JP 2003433880 A JP2003433880 A JP 2003433880A JP 2005185241 A JP2005185241 A JP 2005185241A
- Authority
- JP
- Japan
- Prior art keywords
- fermented
- health food
- fermenting
- action
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 239000004480 active ingredient Substances 0.000 claims abstract description 33
- 238000000855 fermentation Methods 0.000 claims abstract description 24
- 230000004151 fermentation Effects 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 230000009471 action Effects 0.000 claims abstract description 18
- 240000006274 Actinidia polygama Species 0.000 claims abstract description 11
- 235000016413 Actinidia polygama Nutrition 0.000 claims abstract description 11
- 235000011472 cat’s claw Nutrition 0.000 claims abstract description 4
- 241000894006 Bacteria Species 0.000 claims description 37
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 32
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 28
- 241000257303 Hymenoptera Species 0.000 claims description 25
- 241000282326 Felis catus Species 0.000 claims description 23
- 241000219173 Carica Species 0.000 claims description 21
- 235000009467 Carica papaya Nutrition 0.000 claims description 21
- 235000014655 lactic acid Nutrition 0.000 claims description 16
- 239000004310 lactic acid Substances 0.000 claims description 16
- 241001137251 Corvidae Species 0.000 claims description 6
- 235000014138 Caesalpinia decapetala Nutrition 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 230000000202 analgesic effect Effects 0.000 abstract description 16
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 12
- 239000004615 ingredient Substances 0.000 abstract description 5
- 244000003240 Caesalpinia gilliesii Species 0.000 abstract description 3
- 235000014161 Caesalpinia gilliesii Nutrition 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 24
- 230000002195 synergetic effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002519 immonomodulatory effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000023431 Proboscidea parviflora Species 0.000 description 2
- 235000019096 Proboscidea parviflora Nutrition 0.000 description 2
- 241000157352 Uncaria Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000003832 immune regulation Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- JMIAZDVHNCCPDM-ZUNJVLJPSA-N speciophylline Natural products O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H]3[C@H](C)OC=C(C(=O)OC)[C@H]3C[C@@H]21 JMIAZDVHNCCPDM-ZUNJVLJPSA-N 0.000 description 2
- -1 steroid compounds Chemical class 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OJUYFGQEMPENCE-DPKHZRJYSA-N (1s,2r,4as,6ar,6ar,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a,6a-dicarboxylic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C(O)=O)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C OJUYFGQEMPENCE-DPKHZRJYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- PDKKRUPVSFVVFM-UHFFFAOYSA-N Chinovinsaeure Natural products CC1(C)CCC2(C)CCC3(C4CCC5C(C)(C)C(O)CCC5(C(=O)O)C4=CCC3C2(C)C1)C(=O)O PDKKRUPVSFVVFM-UHFFFAOYSA-N 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- LSRNBGXEEKNZHN-UHFFFAOYSA-N Dihydronepetalactone Natural products O=C1OCC(C)C2C1C(C)CC2 LSRNBGXEEKNZHN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- JMIAZDVHNCCPDM-PFDNRQJHSA-N Uncarine E Chemical compound O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H]3[C@H](C)OC=C(C(=O)OC)[C@H]3C[C@H]21 JMIAZDVHNCCPDM-PFDNRQJHSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009390 immune abnormality Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000004095 oxindolyl group Chemical class N1(C(CC2=CC=CC=C12)=O)* 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、発酵健康食品及びその製造方法に関するものである。 The present invention relates to a fermented health food and a method for producing the same.
漢方薬の分野において、マタタビ(サルナシ科の植物)は、鎮痛作用や利尿作用,強心作用を有することが知られている。 In the field of Chinese medicine, it is known that matatabi (a plant of the Sarnasidaceae) has an analgesic action, a diuretic action, and a cardiotonic action.
また、蟻は、鎮痛作用や抗炎症作用、免疫調整作用(特に関節リウマチ,肝炎,免疫性異常等)や老化防止作用(精力強化)を有することが知られている。 Ants are known to have analgesic action, anti-inflammatory action, immune regulation action (particularly rheumatoid arthritis, hepatitis, immune abnormality, etc.) and anti-aging action (enhancement of energy).
また、キャッツクロウ(Uncaria(カギカズラ)属 tomentosa(トメントサ)種 Rubiaceae(アカネ)科 俗名:UNA DE GATO。ペルーアマゾン源流の海抜800m以上の高地に自生する蔓性植物。)は、沈痛・鎮静作用,抗炎症作用,免疫力増強作用及び血行改善作用を有することが知られている。 In addition, cats crow (Uncaria genus tomentosa species Rubiaceae family name: UNA DE GATO, a vine plant that grows naturally in the highland above 800m above sea level in the Peruvian Amazon). It is known to have an anti-inflammatory action, an immunity enhancing action, and a blood circulation improving action.
ところで、上記鎮痛作用や抗炎症作用等を発揮する有効成分を含有した蟻,マタタビ若しくはキャッツクロウを、そのまま例えば複数併用して服用しても、複数併用しただけの効能を得ることは難しい。 By the way, even if an ant, a matabi or a cat's crow containing an active ingredient exhibiting the above-mentioned analgesic action or anti-inflammatory action is taken as it is in combination, for example, it is difficult to obtain the effect of using it in combination.
これは、詳細は不明であるが、人体が吸収できる有効成分の量がある程度の量に限られているためと考えられる。 Although the details are unknown, it is considered that the amount of the active ingredient that can be absorbed by the human body is limited to a certain amount.
本発明は、鎮痛作用,抗炎症作用等を発揮する有効成分を含有したマタタビ,蟻及びキャッツクロウを、発酵作用を有する発酵菌により発酵させることで各々の有効成分をなじませ、これにより、有効成分同志の相乗効果が得られる状態とし、また、該発酵により有効成分が体内に吸収され易い状態とすることで、秀れた相乗効果を発揮し得る有効成分を体内に良好に吸収して鎮痛作用をはじめとする効能を極めて良好に発揮することができるこれまでにない発酵健康食品及びその製造方法を提供するものである。 The present invention adapts each active ingredient by fermenting a matabi, ant and cat's crow containing active ingredients that exert analgesic action, anti-inflammatory action, etc., by fermenting them with fermenting bacteria having a fermenting action. In a state where the synergistic effect of the ingredients can be obtained, and by making the active ingredient easy to be absorbed into the body by the fermentation, the active ingredient that can exhibit an excellent synergistic effect is well absorbed in the body and analgesia The present invention provides an unprecedented fermented health food and a method for producing the same that can exhibit the effects including the action extremely well.
添付図面を参照して本発明の要旨を説明する。 The gist of the present invention will be described with reference to the accompanying drawings.
発酵作用を有する発酵菌を含んだ発酵液と、該発酵液により発酵されるマタタビ,蟻及びキャッツクロウとから成ることを特徴とする発酵健康食品に係るものである。 The present invention relates to a fermented health food comprising a fermented liquid containing fermenting bacteria having a fermenting action, and matatabi, ants and cat's crow fermented by the fermented liquid.
また、請求項1記載の発酵健康食品において、発酵菌として酵母菌及び乳酸菌が採用されていることを特徴とする発酵健康食品に係るものである。 The fermented health food according to claim 1, wherein yeast and lactic acid bacteria are employed as fermenting bacteria.
また、請求項1,2いずれか1項に記載の発酵健康食品において、マタタビとして該マタタビから有効成分を抽出せしめたマタタビ抽出液が採用されていることを特徴とする発酵健康食品に係るものである。 Further, in the fermented health food according to any one of claims 1 and 2, it relates to a fermented health food characterized in that a matahabi extract obtained by extracting an active ingredient from the matahabi is used as the matahabi. is there.
また、請求項1〜3いずれか1項に記載の発酵健康食品において、パパイヤを酵母菌及び乳酸菌により発酵して得られる発酵パパイヤが加えられたことを特徴とする発酵健康食品に係るものである。 The fermented health food according to any one of claims 1 to 3, wherein a fermented papaya obtained by fermenting the papaya with yeast and lactic acid bacteria is added. .
また、マタタビ,蟻及びキャッツクロウを含有した発酵健康食品の製造方法であって、発酵作用を有する発酵菌を含んだ発酵液によりマタタビ,蟻及びキャッツクロウを発酵させて製造することを特徴とする発酵健康食品の製造方法に係るものである。 Moreover, it is a method for producing fermented health foods containing matabi, ants and cat's crow, characterized by fermenting matabi, ants and cat's crow with fermented liquor containing fermenting bacteria having fermenting action The present invention relates to a method for producing fermented health food.
また、請求項5記載の発酵健康食品の製造方法において、発酵菌として酵母菌及び乳酸菌を採用したことを特徴とする発酵健康食品の製造方法に係るものである。 The method for producing a fermented health food according to claim 5, wherein yeast and lactic acid bacteria are employed as fermenting bacteria.
また、請求項5,6いずれか1項に記載の発酵健康食品の製造方法において、マタタビとして該マタタビから有効成分を抽出せしめたマタタビ抽出液を採用したことを特徴とする発酵健康食品の製造方法に係るものである。 The method for producing fermented health food according to any one of claims 5 and 6, wherein a matababi extract obtained by extracting an active ingredient from the matababi is used as the matata. It is related to.
また、請求項5〜7いずれか1項に記載の発酵健康食品の製造方法において、マタタビの発酵前に蟻を発酵液に混合することを特徴とする発酵健康食品の製造方法に係るものである。 Moreover, in the manufacturing method of the fermented health food of any one of Claims 5-7, it relates to the manufacturing method of the fermented health food characterized by mixing an ant into a fermented liquor before fermentation of a matabi. .
また、請求項5〜8いずれか1項に記載の発酵健康食品の製造方法において、マタタビの発酵前若しくは発酵途中にキャッツクローを混合することを特徴とする発酵健康食品の製造方法に係るものである。 Moreover, in the manufacturing method of the fermented health food of any one of Claims 5-8, it concerns on the manufacturing method of the fermented health food characterized by mixing a cat's claw before or during fermentation of a matabi. is there.
また、請求項5〜9いずれか1項に記載の発酵健康食品の製造方法において、マタタビの発酵前若しくは発酵途中に、パパイヤを酵母菌及び乳酸菌により発酵して得られた発酵パパイヤを混合することを特徴とする発酵健康食品の製造方法に係るものである。 Moreover, in the manufacturing method of the fermented health food of any one of Claims 5-9, mixing the fermented papaya obtained by fermenting a papaya by yeast and lactic acid bacteria before or during fermentation of a matabi The present invention relates to a method for producing a fermented health food.
本発明は上述のように構成したから、鎮痛作用,抗炎症作用等を発揮する有効成分を含有したマタタビ,蟻及びキャッツクロウを、発酵作用を有する発酵菌により発酵させることで各々の有効成分をなじませ、これにより、有効成分同志の相乗効果が得られる状態とし、また、該発酵により有効成分が体内に吸収され易い状態となることで、秀れた相乗効果を発揮し得る有効成分を体内に良好に吸収して鎮痛作用をはじめとする効能を極めて良好に発揮することができるこれまでにない発酵健康食品及びその製造方法となる。 Since the present invention is configured as described above, each active ingredient is fermented by fermenting bacteria having a fermenting effect on matabi, ants and cat crows containing active ingredients that exhibit analgesic action, anti-inflammatory action, etc. As a result, a synergistic effect between active ingredients can be obtained, and the active ingredient can be easily absorbed into the body by the fermentation, so that an active ingredient that can exhibit an excellent synergistic effect is obtained in the body. The present invention provides an unprecedented fermented health food and a method for producing the same, which can be absorbed well and exhibit very good effects including analgesic action.
本発明は、繰り返し行った実験の作用効果を請求項としてまとめたものである。 The present invention summarizes the effects of repeated experiments as claims.
本発明の作用は以下のように推測される。 The effect | action of this invention is estimated as follows.
発酵作用を有する発酵菌を含んだ発酵液に、マタタビ,蟻及びキャッツクロウを加えると、マタタビ,蟻及びキャッツクロウは前記発酵液の発酵作用により発酵され溶解する。 When matabi, ants and cat's crow are added to a fermented liquid containing fermenting bacteria having a fermenting action, the matabi, ants and cat's crow are fermented and dissolved by the fermenting action of the fermented liquid.
この際、マタタビ,蟻及びキャッツクロウは発酵液によって共に発酵されることで夫々の有効成分が互いに作用し合い、秀れた相乗効果を発揮し得る状態となる。 At this time, matabi, ants and cat's crow are fermented together by the fermented liquid, so that the respective active ingredients interact with each other, and an excellent synergistic effect can be exhibited.
また、マタタビ,蟻及びキャッツクロウは発酵液によって十分に溶解されることで分子量が小さい状態となり、これにより、該マタタビ,蟻及びキャッツクロウに含まれる有効成分は人体に吸収され易い状態となる。 In addition, the matabi, ants and cat crows are sufficiently dissolved by the fermentation solution to have a low molecular weight, whereby the active ingredients contained in the matabi, ants and cat crows are easily absorbed by the human body.
従って、マタタビ,蟻及びキャッツクロウに含まれる有効成分、即ち、鎮痛作用や抗炎症作用等を発揮し得る有効成分を互いになじませより活性化した状態にでき、更に、該活性化した相乗効果を発揮し得る有効成分を体内に極めて吸収し易い状態にでき、これにより、服用することで、上記マタタビ,蟻及びキャッツクロウを単に併用して服用したのでは得られない秀れた効能を得ることができる画期的な発酵健康食品となる。 Therefore, the active ingredients contained in matababi, ants and cats crows, that is, active ingredients capable of exerting analgesic action, anti-inflammatory action, etc., can be brought into a more activated state by blending with each other, and further, the activated synergistic effect can be achieved. The active ingredient that can be exerted can be easily absorbed into the body, and by taking it, it can obtain excellent effects that can not be obtained by simply taking the above-mentioned matababi, ants and cat's crow together It will be a groundbreaking fermented health food.
本発明の実施例を説明する。 Examples of the present invention will be described.
本実施例は、発酵作用を有する発酵菌を含んだ発酵液と、該発酵液により発酵されたマタタビ,蟻及びキャッツクロウとから成る発酵健康食品に係るものである。 The present embodiment relates to a fermented health food comprising a fermented liquid containing a fermenting bacterium having a fermenting action, and matatabi, ants and cat's crow fermented with the fermented liquid.
発酵作用を有す発酵菌としては、酵母菌及び乳酸菌が採用されている。尚、酵母菌とは、イースト菌,ブドウ酒酵母菌,アルコール酵母菌,ビール酵母菌等、一般的な酵母菌を示す。 Yeast bacteria and lactic acid bacteria are employed as fermenting bacteria having a fermenting action. The yeast refers to general yeast such as yeast, wine yeast, alcohol yeast, and brewer's yeast.
マタタビとしては、該マタタビの葉,枝若しくは幹から有効成分を抽出せしめたマタタビ抽出液が採用されている。 As the matabi, a matababi extract obtained by extracting an active ingredient from the leaves, branches, or trunk of the matabi is used.
マタタビの葉,枝若しくは幹から抽出される有効成分には、マタタビ酸,マタタビラクトン,アクチニジン,ポリガモール等をはじめとする健康に良い作用を与える成分が含まれており、これら成分により、鎮痛作用や抗炎症作用が発揮される。 The active ingredients extracted from the leaves, branches or trunks of matababi include ingredients that have good health effects such as matatabic acid, matatabilactone, actinidine, polygamol, etc. Anti-inflammatory effect is exerted.
漢方薬の分野においては、マタタビがつぼみの頃か開花直前に、該マタタビの子房にマタタビノアブラムシという昆虫が産卵して該子房が異常発育することで形成される木天蓼が、体を温めたり痛みを鎮めたりする作用を有する薬として知られているが、本実施例では、該木天蓼を用いず、前記のように、マタタビの葉,枝若しくは幹を用いてマタタビ抽出液を得るものである。 In the field of herbal medicine, the wood tengu formed by the matabino aphids laying eggs in the pupae of the matababi just before the bud or flowering, Although it is known as a medicine having an action of warming or relieving pain, in this embodiment, as described above, the extract of a matababi extract is obtained using a leaf, a branch, or a trunk of the matababi, without using the wooden bowl. To get.
本実施例において、マタタビの葉,枝若しくは幹を用いてマタタビ抽出液を得たのは、例えばマタタビの実を用いた場合、痛みを鎮める効能を得ることができない為である。 In the present example, the reason why the matababi extract was obtained using the leaves, branches, or stems of the matababi is that, for example, when using the tabata fruit, it is not possible to obtain the effect of relieving pain.
尚、本実施例のマタタビとして、木天蓼から有効成分を抽出したマタタビ抽出液を採用しても良い。 In addition, you may employ | adopt the mata-bi extract which extracted the active ingredient from the wooden tengu as a mata-bi of a present Example.
蟻としては、市販されている乾燥状態の蟻が採用されている。 As the ant, a commercially available dry ant is employed.
また、蟻は、粉砕により粉末化されたものが採用されている。 In addition, ants that have been pulverized by pulverization are employed.
これは、蟻の甲からは非常に硬い為、予め粉砕して粉末化しておくことで、発酵菌の発酵作用により発酵溶解し易くする為である。 This is because it is very hard from the ant shell, and is pulverized and powdered in advance so that it can be easily dissolved by fermentation due to the fermenting action of the fermenting bacteria.
蟻には、グルタミン酸,アラニンをはじめとする28種類のアミノ酸や蟻酸、ビタミンB1 ,ビタミンB12 ,ビタミンE等のビタミン類、ミネラル,カルシウム,リン,鉄,セレン,亜鉛等の微量元素、多種類の酵素,ステロイド類化合物,テルペノイド化合物(サポニン),シトロメラール(健身成分)等の様々な健康に良い作用を与える成分が含まれており、これら成分により、免疫調節作用(特に間接リウマチ,肝炎,免疫性異常等)や老化防止作用(精力強化)や抗炎症作用や鎮痛作用等を発揮することができる。 Ants include 28 kinds of amino acids such as glutamic acid and alanine, formic acid, vitamins such as vitamin B 1 , vitamin B 12 and vitamin E, trace elements such as minerals, calcium, phosphorus, iron, selenium and zinc, It contains various health-friendly components such as various enzymes, steroid compounds, terpenoid compounds (saponins), citromelal (healthy ingredients), and these ingredients make immunomodulating effects (especially indirect rheumatism, hepatitis, Immunological abnormalities, etc.), anti-aging action (enhancement of vigor), anti-inflammatory action, analgesic action, etc. can be exhibited.
キャッツクロウ(Uncaria(カギカズラ)属 tomentosa(トメントサ)種 Rubiaceae(アカネ)科 俗名:UNA DE GATO。)は、ペルーアマゾン源流の海抜800m以上の高地に自生する蔓性植物であり、該キャッツクロウには、6種類のオキシインドールアルカロイド(プテロポディン,イソプテロポディン,ミトラフィン,イソミトラフィリン,リンコフィリン,イソリンコフィリン)、ポリフェノール、アントシアニン、テルペン、キノビック酸,植物性ステロール,タンニン等の様々な健康に良い作用を与える成分が含まれており、これら成分により、鎮痛作用,沈静作用,抗炎症作用,免疫力増強作用,血行改善作用等を発揮することができる。 Cats crow (Uncaria genus tomentosa species Rubiaaceae (common name: UNA DE GATO)) is a vine that grows naturally in the highland above 800m above sea level in the Peruvian Amazon. , 6 kinds of oxindole alkaloids (pteropodin, isopteropodin, mitrafine, isomitrafilin, lincophylline, isolinocophylline), polyphenols, anthocyanins, terpenes, quinovic acid, plant sterols, tannins, etc. These components can exert analgesic action, calming action, anti-inflammatory action, immunity enhancing action, blood circulation improving action, and the like.
本実施例の発酵健康食品には、更に、パパイヤを酵母菌及び乳酸菌により発酵して得られる発酵パパイヤが加えられている。 Fermented papaya obtained by fermenting papaya with yeast and lactic acid bacteria is further added to the fermented health food of this example.
この発酵パパイヤとしては、特開2001−120224号公報に記載の製造方法により製造される発酵パパイヤ液が採用されている。 As this fermented papaya, fermented papaya liquid produced by the production method described in JP-A No. 2001-120224 is employed.
即ち、発酵パパイヤ液は、パパイヤ(例えば国産品のパパイヤ)をスライス若しくはミンチにより細分化し、続いて、糖類を加えて浸透圧によりパパイヤ細胞中のエキスをパパイヤ細胞外に抽出し、続いて、イースト菌やブドウ酒酵母菌等の酵母菌を加え毎日1回以上撹拌操作して該酵母菌及びパパイヤに元々付着している野生酵母菌を6日間乃至8日間発酵繁殖させ、続いて、乳酸菌を加えpH3.5乃至pH4.0に保持しつつ10日間乃至15日間前記酵母菌,野生酵母菌及び乳酸菌を共生培養し、続いて、プレスにより液分を区分し、該液分に更にイースト菌やブドウ酒酵母菌等の酵母菌及び乳酸菌を加えつつ20日乃至60日の発酵熟成を行うことで形成される。 That is, the fermented papaya liquid is obtained by subdividing papaya (for example, domestic papaya) by slicing or mincing, then adding sugar and extracting the extract in the papaya cell by osmotic pressure, followed by yeast And yeast such as wine yeast are added and stirred once or more every day to ferment and propagate the yeast and the wild yeast originally attached to the papaya for 6 to 8 days, followed by addition of lactic acid and pH 3 The yeast, wild yeast and lactic acid bacteria are co-cultivated for 10 to 15 days while being maintained at pH 5.0 to pH 4.0, and then the liquid is separated by pressing, and the yeast and wine yeast are further separated into the liquid. It is formed by carrying out fermentation aging for 20 to 60 days while adding yeasts such as bacteria and lactic acid bacteria.
この発酵パパイヤ液は、体内摂取すると、腸内細菌のバランス、即ち、善玉細菌(代表的なものは乳酸菌)と悪玉細菌(代表的なものはウェルシュ菌)とのバランスを整える作用を発揮し、具体的な効果として確認されているものは、血液の浄化、細胞の活性化、血液循環の改善、動脈硬化の予防、消化吸収代謝の向上(即ち、栄養循環の向上)、病原菌,有害菌の増殖抑制及び感染抑制、免疫系の賦活、ホルモン,ビタミンの生産増大、有害物質,発癌物質の分解及び排泄促進、腸内pHの安定、腸活動の活発化、脂質代謝、糖代謝の改善、肝腎機能の活性化及び保全等が上げられる。 When ingested in the body, this fermented papaya liquid exerts an effect of adjusting the balance of enteric bacteria, that is, the balance between good bacteria (typically lactic acid bacteria) and bad bacteria (typically Clostridium perfringens), Specific effects that have been confirmed include blood purification, cell activation, improvement of blood circulation, prevention of arteriosclerosis, improvement of digestion and absorption metabolism (ie, improvement of nutrient circulation), pathogenic bacteria, harmful bacteria Inhibition of growth and infection, activation of immune system, increased production of hormones and vitamins, decomposition of harmful substances and carcinogens, promotion of excretion, stabilization of intestinal pH, activation of intestinal activity, improvement of lipid metabolism, glucose metabolism, liver and kidney Function activation and maintenance can be improved.
以下、更に具体的に説明する。 More specific description will be given below.
先ず、蟻(例えば3.5kg乃至6.5kg)に発酵パパイヤ液(例えば12リットル乃至22リットル)と水(例えば17リットル乃至31リットル)とを混合し、該混合物に酵母菌(例えば1.0g乃至2.0g)及び乳酸菌(例えば0.35g乃至0.65g)を接種すると、およそ10時間乃至30時間後に発酵が開始される。 First, ant (eg, 3.5 kg to 6.5 kg) is mixed with fermented papaya liquid (eg, 12 liters to 22 liters) and water (eg, 17 liters to 31 liters), and yeast (eg, 1.0 g) is added to the mixture. To 2.0 g) and lactic acid bacteria (eg 0.35 to 0.65 g), the fermentation starts after approximately 10 to 30 hours.
この際の発酵は、室温がおよそ20℃乃至40℃の状態で行う。 The fermentation at this time is performed at a room temperature of about 20 ° C to 40 ° C.
これにより、蟻の発酵溶解が進行する。 Thereby, fermentation dissolution of ants proceeds.
続いて、前記酵母菌及び乳酸菌の接種から、およそ24時間乃至48時間経過後にマタタビ抽出液(例えば28リットル乃至52リットル)及びキャッツクロウ(例えば24kg乃至46kg)を混合する。 Subsequently, after 24 hours to 48 hours have elapsed from the inoculation with the yeast and lactic acid bacteria, a matabi extract (for example, 28 liters to 52 liters) and a cat crow (for example, 24 kg to 46 kg) are mixed.
このマタタビ抽出液は、マタタビの葉,枝もしくは幹を十分な量の水に加えて加熱し、沸騰した後およそ1時間煮込んで濃縮し、その後、ろ過することで形成される。 This matababi extract is formed by adding a matababi leaf, branch, or trunk to a sufficient amount of water, heating, boiling, boiling and concentrating for about 1 hour, and then filtering.
続いて、更に前記発酵パパイヤ液(例えば12リットル乃至22リットル)を混合すると共に酵素原液(例えば0.35リットル乃至0.65リットル)を混合し、およそ10時間乃至30時間発酵させる。 Subsequently, the fermented papaya liquid (for example, 12 liters to 22 liters) is further mixed and the enzyme stock solution (for example, 0.35 liters to 0.65 liters) is mixed and fermented for about 10 hours to 30 hours.
続いて、前記発酵時間経過後、澱粉(例えば1.8kg乃至3.4kg)を混合し、更に発酵させて発酵乾燥させる。 Subsequently, after the fermentation time has elapsed, starch (for example, 1.8 kg to 3.4 kg) is mixed, further fermented, and fermented and dried.
この発酵乾燥は、およそ7日間乃至15日間かけて行う。 This fermentation and drying is performed over approximately 7 to 15 days.
続いて、乾燥した発酵物を粉砕し、粉末化して製品化する。 Subsequently, the dried fermented product is pulverized and powdered to produce a product.
尚、発酵は、室温が20℃乃至40℃の状態で行う。また、この際、発酵物の水分を50%(重量)乃至80%(重量)程度に保持して行うことが望ましい。 Fermentation is performed at a room temperature of 20 ° C to 40 ° C. At this time, it is desirable to carry out the fermentation while keeping the water content of the fermented product at about 50% (weight) to 80% (weight).
本実施例は上述のようにするから、マタタビ,蟻及びキャッツクロウに含まれる有効成分、即ち、鎮痛作用や抗炎症作用等を発揮し得る有効成分をより活性化でき、且つ、体内に非常に吸収され易い状態にでき、これにより、服用することで、上記マタタビ,蟻及びキャッツクロウを単に併用して服用したのでは得られない秀れた効能を得ることができる発酵健康食品を製造することができる。 Since the present embodiment is as described above, the active ingredient contained in the matababi, ants and cat's crow, that is, the active ingredient capable of exerting an analgesic action, an anti-inflammatory action, etc. can be more activated, and it is very much in the body. To produce a fermented health food that can be easily absorbed, and that can be used to obtain excellent effects that cannot be obtained by simply taking the above-mentioned matababi, ants and cat's crow together. Can do.
即ち、本実施例は、マタタビ,蟻及びキャッツクロウを発酵液によって共に発酵させることで夫々の有効成分を互いに作用させ合い、該有効成分が活性化した状態にすることができ、更に、マタタビや蟻等は発酵され溶解することで体内に吸収され易い状態となっている為、活性化したマタタビや蟻等の種々の有効成分を効率良く体内に吸収し、該有効成分の相乗効果により、単にマタタビ等を複数併用したのでは得られない秀れた効能を服用により得ることができる。 That is, in this example, matabi, ants and cats crow are fermented together with a fermentation broth so that the active ingredients can interact with each other, and the active ingredients can be activated. Since ants etc. are in a state that is easily absorbed into the body by being fermented and dissolved, various active ingredients such as activated matabi and ants are efficiently absorbed into the body, and due to the synergistic effect of the active ingredients, The superior effect that cannot be obtained by using a combination of two or more matatabi can be obtained by taking it.
また、本実施例は、腸内細菌のバランスを整える作用を有する発酵パパイヤ液が混合されている為、前記体内に吸収され易い状態の活性化した有効成分を、腸内細菌のバランスを整えつつ体内に吸収することができる為、該有効成分をより一層効率良く良好に吸収することができる。 Moreover, since the fermented papaya liquid which has the effect | action which adjusts the balance of intestinal bacteria is mixed in this Example, the activated active ingredient in the state which is easy to be absorbed in the said body is adjusting the balance of enteric bacteria. Since it can be absorbed into the body, the active ingredient can be absorbed more efficiently and well.
本実施例は、服用することで、秀れた鎮痛効果,抗炎症効果,免疫調整効果,老化防止効果,免疫増強効果,血行改善効果が得られることを確認している。 This example confirms that an excellent analgesic effect, anti-inflammatory effect, immune regulation effect, anti-aging effect, immune enhancement effect, and blood circulation improvement effect can be obtained by taking this example.
本実施例の発酵健康食品には、更にコラーゲンやヒアルロン酸を加えると、より鎮痛作用や免疫調整作用の点で秀れた発酵健康食品となる。 When collagen and hyaluronic acid are further added to the fermented health food of this example, the fermented health food is more excellent in terms of analgesic action and immunomodulating action.
この場合のコラーゲン及びヒアルロン酸は、本出願人の特願2002−347429号(発明の名称:豚皮と鶏冠を用いた健康食品及びその製造方法)に記載の健康食品(以下、先願という。)を混合すると良い。 Collagen and hyaluronic acid in this case are referred to as a health food (hereinafter referred to as a prior application) described in Japanese Patent Application No. 2002-347429 (name of the invention: health food using pork skin and chicken crown and manufacturing method thereof). ).
即ち、先願は、本実施例の全体重量に対して5%(重量)乃至15%(重量)加えると、前述の鎮痛作用や免疫調整作用の点で秀れた効能を発揮できる点を実験により確認した。 That is, the prior application is an experiment that demonstrates that when the 5% (weight) to 15% (weight) is added to the total weight of the present embodiment, the above-mentioned analgesic action and immunomodulating action can be excellent. Confirmed by
以下に、本実施例の具体的な作用効果を示す臨床例を示す。 Hereinafter, clinical examples showing specific effects of the present embodiment will be shown.
両膝に激痛がある60代女性が、本実施例の発酵健康食品を朝晩食後2錠ずつ服用したところ、およそ1週間で両膝の痛みが引いたのを確認した。 A woman in her 60s who had severe pain in both knees took two tablets of the fermented health food of this example after eating in the morning and evening, and it was confirmed that pain in both knees had subsided in about one week.
また、長年、夜も眠れない程のひどい腰痛,足痛に悩まされていた70代女性が、本実施例の発酵健康食品を1日3回、2カプセルずつ服用したところ、およそ2週間で痛みが引いたのを確認した。また、服用し始めてから肌のつやが良くなっていくことも確認した。 A woman in her 70s who had been suffering from severe back pain and foot pain that could not sleep at night for many years took 2 fermented health foods of this example 3 times a day. I confirmed that it was pulled. It was also confirmed that the skin became better after taking the medicine.
以上の実験結果から、本実施例の発酵健康食品は、秀れた鎮痛効果が得られ、また、体を活性化することができるといえる。 From the above experimental results, it can be said that the fermented health food of the present example has an excellent analgesic effect and can activate the body.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003433880A JP3984953B2 (en) | 2003-12-26 | 2003-12-26 | Health food manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003433880A JP3984953B2 (en) | 2003-12-26 | 2003-12-26 | Health food manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005185241A true JP2005185241A (en) | 2005-07-14 |
JP3984953B2 JP3984953B2 (en) | 2007-10-03 |
Family
ID=34791130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003433880A Expired - Lifetime JP3984953B2 (en) | 2003-12-26 | 2003-12-26 | Health food manufacturing method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3984953B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016125208A1 (en) * | 2015-02-03 | 2016-08-11 | 敦子 森田 | Material having swiftlet nest as raw material, composition, and method for producing material |
-
2003
- 2003-12-26 JP JP2003433880A patent/JP3984953B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016125208A1 (en) * | 2015-02-03 | 2016-08-11 | 敦子 森田 | Material having swiftlet nest as raw material, composition, and method for producing material |
JPWO2016125208A1 (en) * | 2015-02-03 | 2017-11-16 | 敦子 森田 | Raw material, composition, and raw material production method using swallow nest |
Also Published As
Publication number | Publication date |
---|---|
JP3984953B2 (en) | 2007-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104106830B (en) | A kind of solid composite for relieving the effect of alcohol | |
KR101738594B1 (en) | Prepatation method of black platycodon syrup and black platycodon syrup | |
JP4616413B1 (en) | Fermented food manufacturing method and fermented food | |
CN101485789A (en) | Camellia chrysantha polysaccharide lozenge and method for producing the same | |
JP2009178084A (en) | Method for producing enzyme-containing health food, and health food | |
CN103013767B (en) | Method for preparing pumpkin sparkling wine | |
CN102703408A (en) | Method for extracting glutamic acid decarboxylase from banana peel and method for producing r-reanal | |
CN104273629A (en) | Honey vinegar drink | |
CN103725479A (en) | Five-bean health-care wine and preparation method thereof | |
CN106497723A (en) | A kind of fruit wine for being mixed brew by walnut flower, leaf of Semen Juglandis, Partition in Fructus Juglandis and walnut shell | |
CN106387582A (en) | Method of preparing enzymes by fermenting cereals | |
KR101663379B1 (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
CN110200179A (en) | A kind of Morinda Citrifolia juice and preparation method thereof that is anti-oxidant, improving immunity | |
CN103798751A (en) | Truffle nutritional tablets | |
CN106235318A (en) | The method preparing ferment for primary raw material with Flos Lonicerae, Rhizoma Curcumae Longae | |
CN103497867B (en) | Mango banana fruit wine and production method thereof | |
CN109329926A (en) | One kind rescuing heart dish ferment and preparation method thereof | |
KR100698390B1 (en) | Making method of garlric drink and garlic drink made thereby | |
CN103301321A (en) | Thrombolytic active polysaccharide mixture preparation technology | |
KR20190045703A (en) | Manufacturing method for functional human microbiome fermented composition | |
KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
JP3984952B2 (en) | Health food manufacturing method | |
CN103756846A (en) | Method for making fermented type low-alcohol honey beverage | |
CN103734852B (en) | Preparation method of aspergillus-oryzae fermented beverage based on wheat-bran bean pulp | |
JP3984953B2 (en) | Health food manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070521 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070611 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070709 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3984953 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 3 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 3 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 3 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110713 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120713 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120713 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130713 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |